Browsing Tag

Hepion Pharmaceuticals

Hepion Pharmaceuticals to Present at the Q1 Investor Summit Conference

Eli Pacheco Mar 8, 2022 0

EDISON, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven…

Health

Hepion Pharmaceuticals Announces USAN Selection of “Rencofilstat” as Nonproprietary…

Eli Pacheco Jan 7, 2022 0

EDISON, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven…

Health

Hepion Pharmaceuticals Receives FDA Fast Track Designation for CRV431 for the…

Eli Pacheco Nov 30, 2021 0

EDISON, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven…

Health

All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431

Eli Pacheco Sep 30, 2021 0

EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven…

Newer Posts